Right now the price per share is 40,19$, Biohaven Pharmaceutical Holding Co Ltd is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Anthony Gentile (Director-Clinical Operations & Finance Program), Charles Conway (Chief Scientific Officer), Elyse Stock (Chief Medical Officer), James Engelhart (Chief Financial Officer & Treasurer), Jon Blaskovich (Director-Information Technology), Lisa Stocking (Director-Operations & Regulatory Affairs), Melissa Beiner (Director-Research & Development), Vladimir Coric (Chief Executive Officer & Director) and its address is C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET, NEW HAVEN, Connecticut, 6510, United States.

The closing price of the stock yesterday was desconocido$.

The current range on the same day is from 38,43$ - 41,63$, with a percentage difference of 40,03$ quite wide that helps to be able to do day trading.

Their latest annual data shows an income of desconocido.

The opening price that appears as last recorded is desconocido.

If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.

EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].